CN101124929A - Nutrition balanced mixed oil containing algal oil and producing method thereof - Google Patents
Nutrition balanced mixed oil containing algal oil and producing method thereof Download PDFInfo
- Publication number
- CN101124929A CN101124929A CNA2007100358007A CN200710035800A CN101124929A CN 101124929 A CN101124929 A CN 101124929A CN A2007100358007 A CNA2007100358007 A CN A2007100358007A CN 200710035800 A CN200710035800 A CN 200710035800A CN 101124929 A CN101124929 A CN 101124929A
- Authority
- CN
- China
- Prior art keywords
- oil
- dha
- epa
- dpa
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a nutrition even blend oil which contains seaweed oil. The nutrition even blend oil uses plant grease such as peanut oil and flax seed oil as the material oil, uses seaweed oil as the alloyed oil, uses fat fusible tea polyphenol and vitamin E as the anti-crawl oxidant. The accession volume can be calculated according to the physiology and the nutrition need of different people and the fatty acid content of the oil; each 100 gram finished blend oil contains: SFA 12 to 18 grams, MUFA 39 to 46 grams, Omega-6 PUFA 31 to 38 grams, Omega-3 PUFA 5 to 9 grams; wherein, Omega-3 LCPUFA 0.1 to 5.0 grams, DHA:(DPA+EPA) 0.25 to 10:1, DHA:EPA 4:1 to 60:1, or DHA:DPA 2:1 to 10:1, no EPA, or HAD without DPA and EPA. The blend oil has the functions of promoting the brain growth and defending the short sight and the presenile dementia and reducing the cerebrovascular disease.
Description
Technical field
The present invention relates to a kind of edible blend oil that contains additive, particularly a kind of nutrient blend oil and production method thereof.
Background technology
For a long time, China's edible oil and fat health care is not subjected to enough attention always, and various fatty acid compositions are rational allocation not.The intake of aliphatic acid in the relevant meals, the World Health Organization and FAO's suggestion, the aliphatic acid of human body absorption every day is saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=be advisable at 1: 1: 1.And the first two plants fully then a kind of undersupply of fatty acid supplying in the present edible oil of China, but polyunsaturated fatty acid role in human body still is important, as ω-6 is that linoleic acid and ω-3 are the eicosenoic acids such as prostaglandin, leukotriene and thromboxane that alpha-linolenic acid can generate different series, important biomolecule chemical processes such as the formation of immunological regulation in the participation body, inflammatory reaction and thrombus and dissolving produce significant effects to health.ω-6 is that linoleic acid also can generate the maximum arachidonic acid (AA) of content in the brain (phosphatide) by prolonging carbochain and desaturation effect in human body, and ω-3 to be alpha-linolenic acid can generate the maximum DHA (DHA) of content in brain (phosphatide) and the retina and eicosapentaenoic acid (EPA) and clupanodonic acid (DPA) by prolonging carbochain and taking off full effect in human body.ω-6 such as above-mentioned AA, EPA, DPA, DHA are and ω-3 is that long carbochain polyunsaturated fatty acid all is the indispensable essential fatty acid of human body, are called as long-chain polyunsaturated fatty acid (LCPUFA).Though being linoleic acid, ω-6 can synthesize AA (arachidonic acid) in vivo, DPA, ω-3 is that alpha-linolenic acid can synthesize EPA (acid of peanut pentaene) in vivo, DPA, DHA, but human body need use with a series of enzymes when utilizing synthetic isonomic other polyunsaturated fatty acid of above-mentioned two kinds of essential fatty acids, because competitive inhibitory effect, aggregate velocity is slow in vivo to make it, its synthetic quantity can not satisfy the Human Physiology needs, because the omega-3 unsaturated fatty acid half-life is short, only about 10h, can not accumulate the essential directly additional above-mentioned polyunsaturated fatty acid of old friend's body in the body.Therefore, it is that linoleic acid and ω-3 are alpha-linolenic acid that human body not only needs to provide the ω-6 as synthesis material, also will every day replenishes ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA).
ω-6 is that linoleic acid can obtain from various plants oil, ω-3 is that alpha-linolenic acid can obtain from linseed oil, soybean oil, Canola Oil, Purple Perilla Seed Oil, content is seldom in edible oil for the oil of above-mentioned kind in the prior art, therefore oil with common edible supply ω-3 is the aliphatic acid deficiency, especially lack ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA), people can only replenish by edible all kinds of health products, as edible deep-sea fish oil soft capsules, seal oil soft capsule, little algae fat capsule etc.But consumers in general lack relevant nutrition professional knowledge, can not correctly replenish, and forget easily and take, supply that can not continuous and effective, so both strengthened people's life cost, be difficult to again obtain the balanced nutrients composition, do not reach wholesome purpose, how correctly to replenish is a difficult problem of exploring.(ω-3LCPUFA) is an approach that economically feasible is convenient and practical to replenish ω-3 long-chain polyunsaturated fatty acid in the human body by edible oil.
To correctly replenish grease, should reach following requirement: 1, the aliphatic acid of taking in every day is saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1, the ratio of linoleic acid and the content of alpha-linolenic acid is to be advisable at 4~6: 1, mainly is that ω-6 as synthesis material is that linoleic acid and ω-3 are that alpha-linolenic acid supplies with should be abundant.2, ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) except that synthetic in human body, also need directly replenish every day.3, according to the different needs amount of different crowd to DHA, DPA, EPA, (DHA, DPA, EPA ratio among the ω-3LCPUFA) meet himself needs to make ω-3 long-chain polyunsaturated fatty acid of its acquisition, avoid wherein a certain not enough or excessive, when effectively replenishing, avoid it to have side effects.For this reason, those skilled in the art has done useful trial.Chinese patent CN1483336A disclosed " balanced nutrients ready-mixed oil ", it has stipulated that the ratio of the content of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) is 1: 1, linoleic acid is 4~6: 1 with the ratio of the content of alpha-linolenic acid, but do not consider the ratio of saturated fatty acid, directly do not add ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) yet; Chinese patent CN1448061A discloses the production method of golden imperial fish second generation nutrient blend oil, though it has considered saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) ratio, considered that also ω-6 is that aliphatic acid linoleic acid and ω-3 are the content ratio of aliphatic acid alpha-linolenic acid, but there is following defective in it: 1, directly do not add the how unsaturated essential fatty acid of ω-3 long-chain (ω-3LCPUFA), (ω-3LCPUFA) is that leukotrienes transforms in human body and gets by ω-3 only to the ω of needed by human body-3 long-chain polyunsaturated fatty acid, can not satisfy the human body needs.2, the grease of heterogeneity and proportioning is not provided at the crowd demand of all ages and classes stage and health status.In order to replenish ω-3 is aliphatic acid, and its technical scheme that adopts is the proportion that increases rapeseed oil, and its shared percentage by weight reaches 20~65%, is its Main Ingredients and Appearance, is the purpose of aliphatic acid though this patent has realized additional ω-3, because of rapeseed oil contains erucic acid, promptly along Δ
1322 carbon monoenoic acids, it is a kind of long-chain monounsaturated fatty acids, its carbochain is than the sour four carbon atom that manys of common fats.Erucic acid has no adverse effects for the normal human of health, contains a kind of enzyme that digests erucic acid that decomposes in the human body, and it can destroy the erucic acid of picked-up, is absorbed by the body to enter blood after digestion.Under the cardiovascular function normal condition, it can not cause in the human body the especially fat accumulation of cardiovascular system of some organ, brings out pathology.But for the cardiac, but there is the possibility that causes " myocardium fat deposition ", show according to investigations, the phenomenon of " the myocardium fat deposition " that causes owing to edible rapeseed oil accounts for whole cardiac's 4/5, the U.S. once found from 100 routine cardiac's corpse of dissecting, the erucic acid that truly has in " cardiac muscle fat " exists, and content reaches more than 5.6%.Because accept on a small quantity by behind the erucic acid after the enzymic digestion every day in cardiac's the blood, abnormal cardiovascular function will excess load originally, and easier bringing out " vessel wall thickening " reaches " myocardium fat deposition ", directly endangers healthy.Therefore, it is edible that the ratio of the imperial fish second generation nutrient blend oil of gold is not suitable for the cardiovascular and cerebrovascular patient, improving ω-3 by the ratio that increases rapeseed oil is that content of fatty acid does not have general applicability, does not have the consumer under the prerequisite of relevant nutrient knowledge and can cause adverse effect to the cardiovascular and cerebrovascular diseases people.3, key component in this oil---soybean oil and rapeseed oil are the transgenosis grease.Whether GM food especially exists potential hazard not prove through long-term practice to fetus, baby, child, children and adolescent growth growth to human body.
Chinese patent application CN1398532A disclosed " a kind of preparation method of functional olive oil concentrating agent ", Chinese patent application CN1398533A disclosed " a kind of functional high-grade cooking olive oil and preparation method thereof ", Chinese patent application CN1191677A " a kind of functional natural edible oil " is though added deep sea fish oil in the prescription, but there is following problem in above-mentioned patent application: 1, do not consider fatty acid total amount and form the requirement whether meet the human nutrition equilibrium that the aliphatic acid of taking in every day with human body is not saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1 be a prerequisite interpolation deep sea fish oil; 2, do not mention and do not set forth main active DHA in the deep sea fish oil, EPA physiology and health-care effect yet, more do not analyze the content of DHA and EPA in the deep sea fish oil, must cause that to replenish the indeterminate and additional dosage of purpose inaccurate.In actual applications, because manufacturer is different with specification, (ω-3LCPUFA) DHA is also different with content and the proportioning thereof of EPA for ω in the fish oil-3 long-chain polyunsaturated fatty acid, DHA and the EPA content according to accurate Calculation does not add deep sea fish oil, must cause magnitude of recruitment inaccurate, phenomenon on the low side or higher occur; The physiological requirements of not satisfying human body on the low side, excessive absorption then can be because of the unsaturated double-bond generation peroxidization in its structure, produce lipid peroxide, this is a kind of free radical, be one of hazards that promote old and feeble and generation cancer, body is produced multiple chronic hazard, if come across skin, then form lipofuscin and senile plaque expelling occurs as this lipid peroxide; If come across in the cell, cell function is weakened; The unrighted acid of adiposis patient Excessive Intake easily causes cholelithiasis; Studies have shown that the rising of lipid peroxide is bigger to the harm that atherosclerotic forms than the rising of cholesterol in the blood.3, DHA that is added and EPA weight ratio science not can not satisfy the physiological requirements of different edible objects.EPA can be metabolized to prostacyclin in human body, and then the body sexual function, as the excessive EPA of children taking, the possibility that promotes sex premature is arranged, the inhibition that EPA also has children's intelligence and skeleton development.DHA is easy to enter brain cell by the brain barrier, is present in brain cell and the brain cell projection, and children's excessive use will cause nerve to be overexcited.Therefore, DHA and EPA content proportioning be science not, also can cause the influence healthy to some crowd.Though 4, above-mentioned three kinds of prescription edible oils have added and contain ω-3 long-chain polyunsaturated fatty acid (deep sea fish oil of ω-3LCPUFA) adds heat stabilization test, can keep how many compositions also for unknown after culinary art heating process.
Therefore, the suitable grease of screening from each vegetable oil, add the rational additive of collocation, replenish (the ω-3LCPUFA) of ω-3 long-chain polyunsaturated fatty acid in the human body by edible oil, the nutrient blend oil of different cultivars is provided for different crowd, being an approach that economically feasible is convenient and practical, is again the difficult problem that needs are further explored.
Marine alga, promptly little algae is that a class contains chlorophyllous vegetalitas aquatic microorganisms usually, and for example spirulina is the protobiont of DHA, DPA, EPA, and fish then is the aggregation of mentioned component.From marine algae, separate and be rich in DHA+DPA+EPA; or only contain DHA+DPA; or only contain DHA, do not contain or contain hardly the marine alga algae kind of EPA, do not contain pollutant, edible nutrient solution and carry out scale and cultivate by adding, thereby can produce a large amount of marine algas.With these marine algas is raw material, adopts methods such as supercritical carbon dioxide extracting, can obtain containing the vegetable fat of nutritional labelings such as lipid such as DHA and effective active growth factor.Especially can obtain with relatively low cost being rich in DHA+DPA+EPA, or only contain DHA+DPA, or only contain different types of algal oils such as DHA.Accomplish scale production at present, make the extensive use of algal oil possess economic feasibility.
Because the health-care efficacy of algal oil, it has been made into various forms of health products and has sold on market.But algal oil is joined in the edible oil, make edible oil have health care, yet there are no the report of correlative study at home and abroad, also do not see suitability for industrialized production.
Summary of the invention
The objective of the invention is to overcome the deficiency of prior art, algal oil is joined in the edible oil, make edible oil have health care, and realization suitability for industrialized production, for all ages and classes and type crowd provide dissimilar nutrient blend oils, to satisfy it to variety classes aliphatic acid and to the needs of DHA, DPA, EPA.
Technical scheme of the present invention is:
Moving according to difference, various fatty acid proportions in the vegetable fat (fatty acid proportion of different greases sees Table 1), the ratio that " DRIs " (in October, 2000 publication) of writing with reference to Chinese Soclety of Nutrition recommended Chinese residents, contain ω-3 long-chain polyunsaturated fatty acid (the cardiovascular health-care function type of ω-3LCPUFA) at all ages and classes and type crowd exploitation, pregnant nursling children auxotype, the children and youth auxotype, household economy practical " balanced nutritious " finished product ready-mixed oil series of products satisfy different crowd to variety classes aliphatic acid with to DHA, EPA, DPA physiology and nutritional need.
A kind of nutrient blend oil is characterized in that: it is to add algal oil and make in edible oil.
As to further improvement of the present invention, the addition of described algal oil is that (total content of ω-3LCPUFA) is decided according to contained ω-3 long-chain polyunsaturated fatty acid in the algal oil, promptly contain ω-3 long-chain polyunsaturated fatty acid behind the algal oil in every 100g finished product ready-mixed oil (ω-3LCPUFA) total amount is 0.1~5.0g modulation, and (ω-3LCPUFA) is one or two or more kinds the combination in DHA (DHA), eicosapentaenoic acid (EPA) or the clupanodonic acid (DPA) to described ω-3 long-chain polyunsaturated fatty acid by adding.Described vegetable fat consists of in the two low rapeseed oils of refine peanut oil, refining sunflower oil, refining, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil four or more combination, and the incorporation in the finished product ready-mixed oil of every 100g is:
Refine peanut oil 20.7~43.8g refining sunflower oil 0~27g
The two low rapeseed oil 0~40g purified soyabean oil 0~35g of refining
Refined sesame oil 0~5g refining linseed oil 0~10.8g
Oil 0~the 28g of refined maize refining Purple Perilla Seed Oil 0~8g
Refining walnut oil 0~5g refining tea-seed oil 0~24g
Refining safflower seed oil 0~5g refined olive oil 0~8g.
As to further improvement of the present invention, in the children and youth auxotype, (ω-3LCPUFA) is DHA (DHA), eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA) to described ω-3 long-chain polyunsaturated fatty acid, described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=2: 1~10: 1, DHA (DHA) is DHA: EPA=4 with eicosapentaenoic acid (EPA) weight ratio R: 1~10: 1.
As to further improvement of the present invention, in the pregnant nursling children auxotype, (ω-3LCPUFA) is DHA (DHA), eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA) to described ω-3 long-chain polyunsaturated fatty acid, described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=2: 1~10: 1, DHA (DHA) is DHA: EPA=10 with the weight ratio R of eicosapentaenoic acid (EPA): 1~60: 1.
As to further improvement of the present invention, in the pregnant nursling children auxotype, (ω-3LCPUFA) is DHA (DHA) and two kinds of combinations of clupanodonic acid (DPA) to described ω-3 long-chain polyunsaturated fatty acid, and described DHA (DHA) and clupanodonic acid (DPA) weight ratio S are DHA: DPA=2: 1~10: 1.
As to further improvement of the present invention, in the pregnant nursling children auxotype, (ω-3LCPUFA) is DHA (DHA) to described ω-3 long-chain polyunsaturated fatty acid.
As to further improvement of the present invention, during household economy is practical, described ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) is DHA (DHA) and eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA), and described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=0.7: 1~2: 1.
As to further improvement of the present invention, in the cardiovascular health-care function type, the weight ratio Q that described DHA (DHA) and clupanodonic acid (DPA) add eicosapentaenoic acid (EPA) is DHA: (EPA+DPA)=0.25: 1~0.7: 1, described vegetable fat consists of in refine peanut oil, refining sunflower oil, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil four or more above combination.
As to further improvement of the present invention, added antioxidant in the described vegetable fat, described antioxidant is one or both the combination in fat-soluble tea polyphenol and the vitamin E, described fat-soluble tea polyphenol addition is to contain 0.002~0.03g in every 100g finished product ready-mixed oil, and described vitamin E addition is to contain 0.01~0.2g in every 100g finished product ready-mixed oil.
A kind of production method of nutrient blend oil is characterized in that comprising the steps:
(1) selected needed raw material edible oil;
(2) (weight ratio between the total amount of ω-3LCPUFA) and DHA, DPA, the EPA requires the algal oil of selected required interpolation according to finished product ready-mixed oil required ω-3 long-chain polyunsaturated fatty acid;
(3) weight ratio between the addition of the following relational expression calculating of foundation algal oil and DHA, DPA, the EPA:
(ω-3LCPUFA) weight (W) with the relational expression of algal oil addition is ω-3 long-chain polyunsaturated fatty acid in per 100 gram finished product ready-mixed oils
W=Wb×Xb
(DHA and EPA weight ratio relational expression are ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid in DHA of ω-3LCPUFA) and EPA weight ratio (R) and the algal oil
R=X
DHA/X
EPA=X
DHAb/X
EPAb
(DHA with (DPA+EPA) weight ratio relational expression is ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid in the DHA of ω-3LCPUFA) and (DPA+EPA) weight ratio (Q) and the algal oil
Q=X
DHA/(X
DPA+X
EPA)=X
DHAb/(X
DPAb+X
EPAb)
(DHA and DPA weight ratio relational expression are ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid in DHA of ω-3LCPUFA) and DPA weight ratio (S) and the algal oil
S=X
DHA/X
DPA=X
DHAb/X
DPAb
ω in the algal oil-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) total amount, DHA, DPA, EPA weight account for the relational expression of its percentage by weight and are:
Xb=X
DHAb+X
DPAb+X
EPAb
In the above-mentioned relation formula:
W be ω-3 long-chain polyunsaturated fatty acid in per 100 gram finished product ready-mixed oils (weight of ω-3LCPUFA), its weight range is 0.1~5.0g;
Wb is the weight of the algal oil that adds in per 100 gram finished product ready-mixed oils; (ω-3LCPUFA) weight (DHA+EPA+DPA) accounts for the percentage of its gross weight to Xb for ω-3 long-chain polyunsaturated fatty acid in the algal oil that adds;
X
DHA, X
EPA, X
DPABe respectively DHA, EPA in the finished product ready-mixed oil, DPA weight accounts for its percentage by weight; X
DHAb, X
EPAb, X
DPAbBe respectively DHA in the algal oil, EPA, DPA weight accounts for its percentage by weight.
(4) according to containing saturated fatty acid (SFA) 12~18g in the 100 gram finished product ready-mixed oils, monounsaturated fatty acids (MUFA) 39~46g, omega 6 polyunsaturated fatty acid (31~the 38g of ω-6PUFA), omega-3 polyunsaturated fatty acids (ω-3PUFA) the requirement of 5~9g, ((percentage composition of ω-3PUFA) is calculated the portion that all kinds of raw material edible oils should add for ω-6PUFA), omega-3 polyunsaturated fatty acids according to saturated aliphatic acid (SFA) in the algal oil of required interpolation, the various raw material edible oil, monounsaturated fatty acids (MUFA), omega 6 polyunsaturated fatty acid.
(5) get the algal oil of calculating portion and the antioxidant of raw material edible oil and ormal weight, add in the material-compound tank, holding temperature is stirred at a slow speed and mixes (general 20~30 minutes) at 20~40 ℃, filters, and promptly gets the ready-mixed oil finished product.
Beneficial effect of the present invention is:
The present invention replenishes ω-3 long-chain polyunsaturated fatty acid by edible oil and fat, and (ω-3LCPUFA) DHA, EPA, DPA avoid other health products to forget and take phenomenon, and reinforcing method is science more.The present invention select for use algal oil as additive realize to replenish ω-3 long-chain polyunsaturated fatty acid (purpose of ω-3LCPUFA) has the following advantages:
1, algal oil contained ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) comprised DHA, EPA, DPA, its effect is respectively:
EPA: be commonly called as " blood vessel street cleaner ", can make certain prostaglandin, this prostaglandin can make angiomalacia and suppress blood platelet and condense in blood vessel, has the vascular sclerosis of preventing, cardiovascular and cerebrovascular embolism, reduces effects such as hypertension, high fat of blood and cholesterol.Be applicable to coronary sclerosis and thrombus, headstroke, cerebral hemorrhage, cerebrovascular disorder, high cholesterol, high fat of blood, hypertension, hand and foot numbness, various cardiovascular and cerebrovascular diseases such as palpitaition.
DHA: be commonly called as " brain gold ", content in optic cell and retinal tissue is up to 40~47%, be aliphatic acid important in brain, nerve, the cellula visualis, have the memory of enhancing and the power to think, improve intelligence, regulate and improve eyesight, reduce the incidence of women's neurasthenia in postpartum and depression, prevention and treatment senile dementia, prevention dry skin and aging, acceleration skeleton increases, preventing effects such as osteoporosis, is that brain tissue and optic nerve are grown and function is brought into play necessary nutriment.
DPA: content height in human milk is that fish oil and other food lack.DPA is for the softness that keeps the arterial blood tube wall, and the flexible effect that promotes vascular wall and EPA are as similar, and Japanese scholar's research thinks that the interior EPA of body only changes into DPA and just can play a role, and DPA exceeds 10~20 times than EPA effect.DPA can promote and improve the immunity of human body, can enter the phospholipid layer of epicyte rapidly, has the special physical action of the cell membrane of reinforcement, promote function of plasma membrane, resist wreaking havoc of free radical, to diabetes, rheumatoid arthritis, psoriasis, asthma, ulcer colo-enteritis etc. all has therapeutic action.The pregnant woman replenishes enough DPA at the initial stage of pregnancy, helps to be pregnant with the sound fetus of the circulatory systems such as heart, blood vessel; DPA is the same with DHA to be formed for people's composition of milk, and part expert thinks that DPA may play an incognizant more important role in the past.
2, marine alga is the protobiont of DHA, DPA, EPA, is to cultivate by the scale of purebred marine alga to obtain, and can produce algal oil with relatively low cost.Different marine alga algae kinds can be produced the algal oil of heterogeneity, can satisfy the needs of different crowd.DHA good stability in the algal oil, has unique marine alga flavor, no fishlike smell, for its extensive use has possessed economic feasibility, especially by separating the purebred algal oil of producing of little algae of the EPA that does not contain or only contain trace, be not subjected to marine pollution, be clean most, safest vegetalitas DHA, be adapted to most to be added in cleaning and safety requirements very high pregnant woman, newborn woman, baby, child and the infant foods.
3, algal oil does not contain cholesterol, avoids causing body's cholesterol higher.As everyone knows, unnecessary LDL-C LDL-C can pierce the arteries endothelium, forms patch, and artery-clogging causes coronary heart disease, cerebral infarction, perhaps causes serious consequences such as myocardial infarction, sudden death along with plaque rupture.
The present invention has compiled the fatty acid proportion of Various Edible fat, see Table 1, moving according to difference, various fatty acid proportions in the vegetable fat, the absorption ratio of various aliphatic acid in China resident's that " DRIs " book of writing with reference to Chinese Soclety of Nutrition is recommended the diet nutritional intake, as shown in table 2, saturated fatty acid (SFA) to different crowd, monounsaturated fatty acids (MUFA), ω-6 is that (ω-6PUFA) and ω-3 are that polyunsaturated fatty acid (ω-3PUFA) calculate by requirement to polyunsaturated fatty acid, draw Chinese residents meals grease intake, as shown in table 3.Concrete computational process is: become the human fatty acid intake to account for 20~30% saturated fatty acids (SFA) of gross energy: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1 ratio, ω in the polyunsaturated fatty acid-6 are that (ω-6PUFA) and ω-3 are that (ω-3PUFA) ratio is 4~6: 1 to polyunsaturated fatty acid to polyunsaturated fatty acid; Eating habit according to China resident, animal food can be brought fractional saturation aliphatic acid into, should deduct animal food in the finished product ready-mixed oil and can bring fractional saturation aliphatic acid into, so its saturated fatty acid (SFA): monounsaturated fatty acids (MUFA): the appropriate ratio of polyunsaturated fatty acid (PUFA) should be 0.35: 1: 1.One day fatty intake=(0.30 * RNI)/36700 of resident, 0.3 should account for the ratio of food intake gross energy for fat, RNI is the energy intake of the Chinese residents meals recommended of Chinese Soclety of Nutrition's " DRIs " of writing, 36700 is the energy that every gram fat produces in the food (J of unit, its value is more lower slightly than the energy 39700J that every gram fat in the body produces).As adult man of 18~49 years old age, be engaged in middle physical exertion, one day fatty intake=0.3 * 11.30 * 1000000 ÷ 36700=92.4g then, calculate its saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) intake thus and be 30.8g (calculating) by 1: 1: 1, ω-6 is that intake is 24.64~26.4g in the polyunsaturated fatty acid (PUFA), and ω-3 is that intake is 6.2~4.4g (calculating by 4~26: 1).Because of the basic balance of aliphatic acid that provides in the loss aliphatic acid in the cooking process and other food, so every day, the edible oil and fat demand still was 92.4g.As known from Table 3, the crowd of all ages and classes, sex, labour intensity fat requirement difference, fatty requirement is up to wet nurse, and every day, the fat requirement was 109.4g, and fatty requirement is minimum be child (young girl) over 1 years old, and every day, fatty requirement was 36.0g.
The present invention has also studied the health care and the medicine fish oil series products usage and dosage of data of literatures such as domestic and international nutrition, pharmacology and authoritative department recommended intake and China Ministry of Public Health and State Food and Drug Administration's approval, as adding the ω-3 long-chain polyunsaturated fatty acid (normative reference of content proportioning between the dosage of ω-3LCPUFA) and DHA, DPA, the EPA in the edible finished product ready-mixed oil of different crowd.
1, the U.S. is healthy advises taking everyone every day 1~3g ω-3 long-chain unsaturated fatty acid (ω-3LCPUFA) jointly with nutrition service department and life science NI; 2, the people that recommended 25~49 years old of Canadian government department absorbs 1.5g ω-3 long-chain unsaturated fatty acid (ω-3LCPUFA) every day; 3, the WHO of the World Health Organization advises that minimum DHA daily intake is 220mg, and the baby should be according to body weight, and each kilogram needs to replenish DHA40mg; 4, FAO of FAO (Food and Agriculture Organization of the United Nation) and the WHO of the World Health Organization, the ratio of advocating DHA/EPA in the infant food is greater than 10; 5, China Ministry of Public Health " food additives use sanitary standard (amendments in 2004) " (actual addition is 0.2~0.6g/kg) to the use amount of regulation DHA nutrition fortifier in babies ' formula milk powder in the baby milk powder as per kilogram 0.4~1.8g; 6, the Jin Aoli board fish oil soft capsule of the enhancing immunity that the crowd takes beyond the suitable infant [the strong word G20070025 of state's food], every day, taking dose was 33% fish oil (every 100g contains: DHA 20.0g, EPA 13.0g) 4000mg, be that the DHA+EPA total amount is 1320mg, the weight ratio of DHA and EPA is 1.54: 1, and wherein DHA content is 800mg; 7, be fit to children's fish oil soft capsule of children taking, every day, taking dose was 30% fish oil, 500~1000mg, and promptly the DHA+EPA total amount is 150~300mg, and the weight ratio of DHA and EPA is 2: 1~5: 1, and wherein DHA content is not less than 100mg; 8, general adult takes fish oil based article such as deep-sea fish oil soft capsules, and every day, taking dose was 30% fish oil, 1000~2000mg, and promptly the DHA+EPA total amount is 300~600mg, and the weight ratio of DHA and EPA is 0.67: 1; 9, medicine ethyl polyenoate capsule and pill [national drug standards WS1-XG-023-2000] regulation taking dose every day that is applicable to the hyperlipemia patient is DHA+EPA total amount 7500~1500mg, and the ratio of DHA and EPA must not be greater than 0.4; 10, improve the luxuriant growth Bi health board algal oil capsule that memory person uses [the strong word G20040547 of state's food], every day taking dose be 20% algal oil (every 100g contains: 675mg DHA 20g), promptly DHA content is 135mg, does not contain EPA; 11, little algae oil DHA soft capsule of Changsha Jia Ge Bioisystech Co., Ltd production, pregnant and ylying-in woman is taken 60% little algae oil (every 100g contains: DHA 42.0g, DPA 18.0g, EPA 0.8g), 500~1000mg every day, be that DHA content is 210~420mg, DPA+EPA content is 94~188mg, and EPA content is 4~8mg; Every day taken 360~720mg by infant's type, and promptly DHA content is 151~302mg, and DPA+EPA content is 68~135mg, and EPA content is 3~6mg; Every day taken 250~500mg by the youngsters and children type, and promptly DHA content is 105~210mg, and DPA+EPA content is 47~94mg, and EPA content is 2~4mg.
The present invention analyzes above-mentioned health care and medicine fish oil series products usage and dosage, to reduce cost as far as possible under the prerequisite that fully satisfies the different crowd psychological need is principle, think: contain in the nutrient blend oil of algal oil every 100g and contain ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) total amount should be 0.1~5.0g, simultaneously product is pressed all ages and classes and type crowd to DHA, the demand difference of EPA is divided into following several types: 1, children and youth auxotype: children, the teenager is in cranial nerve and optic nerve growth and development stage, and is higher to the DHA demand percentage; For promoting and improve the immunity of human body, the healthy development of maintenance cycle system needs a certain amount of DPA; EPA significantly suppresses the arachidonic biosynthesis of endogenous in low age crowd (particularly baby) body, hinder its intelligence and skeleton development, should control its content, children, teenager DHA:(EPA+DPA) should be 2: 1~10: 1, DHA: EPA should be 4: 1~and 10: 1; 2, pregnant nursling children auxotype: fetus, baby, child, pregnant woman, wet nurse are higher to the demand percentage of DHA, DHA: (EPA+DPA) should be 2: 1~10: 1, DHA: EPA should be 10: 1~and 60: 1, or DHA: DPA is 2: 1~10: 1, do not contain EPA, or be DHA, do not contain EPA and DPA (yet suitable children of the pregnant young auxotype of nursling and teenager, but cost is higher relatively); The cardiovascular health-care function type: cardiovascular and cerebrovascular disease patient and the elderly take into account the prevention senile dementia, DHA: (EPA+DPA) should be 0.25: 1~0.7: 1 to reduce blood fat, blood sugar, blood pressure and to eliminate thrombus; Household economy is practical: for common healthy population, based on the prevention cardiovascular and cerebrovascular disease and strengthen memory and improve eyesight, DHA and EPA content proportioning are answered relative equilibrium, DHA: (EPA+DPA) should be 0.7: 1~2: 1.
The present invention has taken into full account the loss in the cooking process, carried out adding heat stabilization test according to the culinary art condition, with reference to ethyl polyenoate quality standard [national drug standards WS1-XG-023-2000], " Pharmaceutical Analysis magazine " the 5th phase in 2004 " capillary gas chromatography " is measured (content of ω-3PUFA) of omega-3 polyunsaturated fatty acids in the algal oil capsule and pill, soybean oil drug standard [" Chinese pharmacopoeia 2005 version two ones] equal size assay method, investigated DPA, DHA, EPA is in the heating stable case that meets under the cooking temp condition, and concrete experiment content is as follows:
1 instrument and reagent
Tianjin, island 17A gas chromatograph, fid detector (flame ionization ditector), gas-chromatography work station.
25% algal oil is available from Changsha Jia Ge Bioisystech Co., Ltd; Methyl eicosapentaenoic acid (EPA, 9.99mg.mL
-1), clupanodonic acid methyl esters (DPA, 9.99mg.mL
-1), 20 carbon, two acid methyl esters (DHA, 9.99mg.mL
-1) reference substance solution is all available from Supelco company, it is pure that boron trifluoride methanol solution [concentration is 50% (w/v)], n-hexane, methyl alcohol, NaOH are analysis.
2, chromatographic condition
Capillary column: Supelco-Wax (30m * 0.53mm, 0.25 μ m); Column temperature: 220 ℃, injector temperature is 250 ℃, 260 ℃ of detector temperatures.Carrier gas is nitrogen (99.99%), and post is pressed and is 42kPa, flow velocity: 2ml.min
-1, linear velocity: 47cm.s
-1, split ratio: 1: 1.
3, precision test
Getting " 4 " concentration is 500ug.mL
-1EPA, DPA, DHA solution, METHOD FOR CONTINUOUS DETERMINATION 5 times, its peak area RSD value is respectively 0.93%, 1.16%, 1.15% (n=5) as a result.
4, linear test
Precision is measured EPA methyl esters (9.99mg.mL respectively
-1), DHA methyl esters (9.99mg.mL
-1) reference substance, DPA methyl esters (9.99mg.mL
-1) reference substance 1ml puts respectively in the 10ml measuring bottle, with the n-hexane dilution and be settled to scale, shakes up product storing solution in contrast.Precision is measured reference substance storing solution stepwise dilution, makes the solution of a series of concentration.Getting the 1uL inject gas chromatograph respectively, measure each peak area, is ordinate (Y) with the peak area of reference substance, and concentration is abscissa (X), carries out linear regression.The regression equation of EPA, DPA, DHA (n=7) is respectively as a result:
Y
EPA=1343.3X
EPA-1784.8 r=0.9999
Y
DPA=1172.8X
DPA-1426.5 r=0.9999
Y
DHA=1040.2X
DHA-1216.2 r=0.9999
All at 5.0-1000ug.mL
-1Be good linear relationship in the concentration range.
5, recovery test
Get the about 100mg of embodiment 1 base oil (not containing alloyd oil), the accurate title, decide, and puts in the 25ml tool plug reaction bulb, and accurate each 1ml of reference substance stock solution that adds makes 3 parts altogether, adds 0.5mol.mL
-1Sodium hydrate methanol solution 2mL, close plug, put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 3mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision adds n-hexane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, after using 5 times of above-mentioned solution of dilution of n-hexane before the sample introduction, precision is measured the 1uL inject gas chromatograph, calculates by external standard method, calculates average recovery rate with the amount of recording and addition.EPA, DPA, DHA average recovery rate are respectively 98.7%, 99.8%, 99.5%, n=3 as a result.
6, repeatability
Get same No. 1 sample a, by " 8.2.1 " method operation down, make 5 parts of need testing solutions, measure by above-mentioned chromatographic condition, the RSD (n=6) that records EPA, DPA, DHA content is respectively 1.56%, 1.48%, 1.35% (n=5).
7, stability
Get same No. 1 sample a, make need testing solution by method operation under " 8.2.1 " item, respectively 0,2,4,6, the 8h sample introduction is measured, and the sample peak area remains unchanged substantially, and the RSD value of EPA, DPA, DHA peak area is respectively 1.53%, 1.42%, 1.23%.
8, sample determination
8.1 sample preparation
No. 1 sample: 60% algal oil
Preparation method: get 60% algal oil that does not heat, be sample a; Get 60% algal oil 50g, by the straight fiery heat temperature raising to 200 of culinary art condition ℃ (heating-up time is 2~3 minutes) sampling rapidly, cooling immediately gets sample b; In 200~250 ℃ of temperature ranges, keep temperature to take a sample with method in the time of 2 minutes, get sample c; Keep temperature to take a sample with method in the time of 4 minutes, get sample d; Temperature retention time was taken a sample with method in the time of 6 minutes, got sample e.
No. 2 samples: get 60% algal oil 5g, be mixed with 100g with embodiment 1 base oil.
Preparation method: prepare sample a, b, c, d, e with " No. 1 sample " method.
8.2 extracting method
8.2.1 No. 1 sample
Get about 100mg, the accurate title, decide, and puts in the 25ml tool plug reaction bulb, adds 0.5mol.mL
-1Sodium hydrate methanol solution 2mL, close plug is put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 3mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision is with normal heptane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, place in 4 ℃ of refrigerators.After using 5 times of above-mentioned solution of dilution of n-hexane before the sample introduction, as need testing solution.
8.2.2 No. 2 samples
Get about 100mg, the accurate title, decide, and puts in the 25ml tool plug reaction bulb, adds 0.5mol.mL
-1Sodium hydrate methanol solution 4mL, close plug is put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 6mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision is with normal heptane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, place in 4 ℃ of refrigerators.Divide before the sample introduction and get supernatant, as need testing solution.
8.3 sample determination
Precision is measured 500ug.mL
-1EPA, DPA, DHA reference substance solution and need testing solution 1uL be inject gas chromatograph respectively, and the record chromatogram calculates test sample EPA, DHA, DPA content by external standard method.The sample size measurement result sees Table 4.
9, blank test
Get embodiment 1 base oil and prepare blank sample with " 8.2.1 " sample extraction method, press the sample size condition determination and measure, the result chromatographic peak do not occur in EPA, DPA, the corresponding retention time of DHA, and base oil is noiseless to assay.
Said method is learned the checking result and is shown that the content assaying method result that this experiment is adopted accurately and reliably.Assay is the result show, algal oil crude oil and finished product ready-mixed oil thereof heat (2~3 minutes heating-up times) when promptly being warming up to 200 ℃ under the culinary art condition, keep temperature in the time of 2,4,6 minutes in 200~250 ℃ again, the total content storage rate of EPA, DPA, DHA is about 98%, 95%, 92%, 90%, and heating is little to its content influence under the culinary art condition; By advocating the cooking methods of science, promptly adding after the ready-mixed oil a little, heat (temperature is no more than 200 ℃) promptly begins dish down, or when taking the dish out of the pot, add ready-mixed oil again, and reduce heating temperature and reduce heated time, can more effectively guarantee (the absorption of ω-3LCPUFA) of ω-3 long-chain polyunsaturated fatty acid.This finished product mediation accent is better as eating in cold dish, the instant food.
The antioxidant fat-soluble tea polyphenol that adds in the finished product ready-mixed oil of the present invention; can protect polyunsaturated fat to avoid oxidation Decomposition such as oxygen radical; keep grease stable, have the lipid metabolism of adjusting again, reduce blood fat, suppress atherosclerotic generation and the incidence of various cardiovascular and cerebrovascular diseases such as development, reduction coronary heart disease and the effect of the death rate.
The antioxidant vitamin E that adds in the finished product ready-mixed oil of the present invention; can be to the peroxidation of Green Tea Extract; the protection polyunsaturated fat is avoided the radical damage oxidation Decomposition; keep grease stable, can protect cell membrane, nerve and muscle to avoid oxygen free radical injury again, keep the normal development and the function of nerve, muscle; the protection red blood cell avoids haemolysis; can also be anti-ageing, protection skin, strengthen ovarian function, prevent habitual abortion.
Cardiovascular and cerebrovascular type nutrient blend oil provided by the present invention has the following advantages:
1, at cardio-cerebral vascular disease patient and middle-aged and old physilogical characteristics, got rid of the rapeseed oil that contains erucic acid, prevented that erucic acid from causing " myocardium fat deposition " phenomenon of cardiovascular functional disorder patient.
2, DHA, DPA, EPA content proportioning science, have following health care: A, reduce cholesterol, angiocardiopathy preventing, the prevention thrombosis reduces artery sclerosis and hypertension, reduction blood viscosity, stimulates circulation, eliminate fatigue, alleviate gout and rheumatic arthritis.The incidence of disease of B, minimizing coronary artery heart disease.The prevention of suitable high cholesterol, artery sclerosis, high fat of blood, hypertension, heart disease, fatty liver, obesity etc.C, improvement memory, the prevention senile dementia; D, protection retina improve eyesight.
3, selected for use have expansion and softening blood vessel, prevent thrombosis, increase blood circulation, pre-anti-aging and regulate the safflower seed oil of effects such as endocrine, safflower seed oil is known as the linoleic acid king by nutrition circle, its linoleic acid content can be up to 80%.
Pregnant nursling children nutrient blend oil provided by the present invention has the following advantages:
1, DHA, DPA, EPA content proportioning science can promote the growth of fetus, baby, child's brain, retina and physical efficiency thereof.
2, the walnut oil of Tian Jiaing has been rich in leukotrienes, vitamin A, vitamin E, folic acid, 18 seed amino acids, carotene, thiamine, flavonol, trace elements such as zinc, manganese, chromium, have brain-tonifying and kidney-nourishing, moisten the lung and relieve the cough, fill blood, effect such as blacking hair and nourishing face, anti-ageing, reducing blood lipid, prevention diabetes, can increase pregnant woman's skin elasticity, alleviate and eliminate cyasma, promote fetal brain tissue development and intelligence to increase.
3, the prescription grease is non-transgenic, has ensured fetus, baby, child's food security.
Children and youth type nutrient blend oil provided by the present invention has the following advantages:
1, DHA, DPA, EPA content proportioning science can promote the growth of brain, retina and physical efficiency thereof, strengthen memory, improve learning ability, improve eyesight.
2, the walnut oil of Tian Jiaing can in time replenish brain nutrition, alleviates and eliminates brain fag, improves memory and thinking, is of value to children, adolescent growth is grown.
3, the prescription grease is non-transgenic, has ensured children, teen-age edible safety.
Economical and practical type nutrient blend oil provided by the present invention has the following advantages:
1, DHA, DPA, EPA content proportioning science, can reduce cholesterol, improve hypertension, adjust blood fat, prevention miocardial infarction, diseases such as headstroke, fatty liver, artery sclerosis, can strengthen memory again, improve learning ability, prevent alzheimer's disease and improve eyesight, satisfy healthy population physiology and nutritional need.
2, considered ordinarily resident's physiology and nutritional need and purchasing power, economical and practical, meet nutrition, health care requirement, it is edible to be fit to common healthy population.
The specific embodiment
Embodiment 1~70 each raw material edible oil, algal oil and antioxidant proportioning composition see Table 5,6.
Its production stage is:
(1) by the selected raw material edible oil of each embodiment (seeing Table 5);
(2) by the selected algal oil of each embodiment (seeing Table 6);
(3) calculate the addition of algal oil according to computing formula;
(4) calculate the portion that all kinds of raw material edible oils should add;
(5) get the antioxidant of the raw material edible oil, algal oil and the ormal weight that calculate portion, evenly mix.
In each embodiment grease prescription, various fatty acid wts in the 100g finished product ready-mixed oil, ω-3 long-chain polyunsaturated fatty acid (ω-3LCPUFA) DHA+DPA+EPA total amount, DHA and (DPA+EPA) weight ratio Q (then being S when EPA content is zero), DHA and EPA weight ratio R see table 6 for details.
Embodiment 1~20 is a cardiovascular health-care function type ready-mixed oil, and embodiment 20~42 is pregnant nursling children nutrient blend oil, and embodiment 43~56 is a children and youth auxotype ready-mixed oil, and embodiment 57~70 is the practical ready-mixed oil of household economy.
The present invention is including but not limited to above-mentioned embodiment, adds the marine alga wet goods and obtain to contain ω-3 long-chain polyunsaturated fatty acid (method of the ready-mixed oil of ω-3LCPUFA) promptly belongs to protection scope of the present invention in grease as long as adopted.
Aliphatic acid is formed in table 1, the edible oil and fat commonly used
The name of an article | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega 6 polyunsaturated fatty acid | Other |
Linseed oil | 12.4 | 20.7 | 16.2 | 50.7 | |
Crust sesame oil | 10.0 | 12.0 | 53.0 | 25.0 | |
25~35% fish oil, polyenoid fish oil | 25.0 | 37.0 | 3.0 | 35.0 | |
45~55% fish oil, polyenoid fish oil | 17.3 | 25.6 | 2.1 | 55.0 | |
65~75% polyenoid fish oil | 9.6 | 14.2 | 1.2 | 75.0 | |
Olive oil | 10.0 | 83.0 | 7.0 | 1.0 | |
Soybean oil | 16.5 | 24.0 | 52.0 | 7.5 | 3 |
Corn oil | 14.8 | 28.3 | 55.8 | 1.1 | 2 |
Peanut oil | 19.1 | 42.9 | 37.3 | 0.7 | |
Rapeseed oil | 7.2 | (63.5 wherein erucic acid 0-42) | 19.6 | 9.7 | |
Cottonseed oil | 28.0 | 25.0 | 44.0 | 0 | |
Sunflower oil | 13.6 | 23.1 | 61.6 | 1.7 | |
Tea-seed oil | 10.0 | 79.0 | 10.0 | 1.0 | |
Safflower seed oil | 9.0 | 13.2 | 76.6 | 1.2 | |
Wheat-germ oil | 5.0 | 15.0 | 70.0 | 10.0 | |
Walnut oil | 10.0 | 23.0 | 58.0 | 9.0 | |
Sesame oil | 15.0 | 38.0 | 46.0 | 0.3 | 1 |
Rice bran oil | 21.0 | 43.0 | 33.0 | 3.0 | |
Palm oil | 44.0 | 44.0 | 12.0 | ||
Purple Perilla Seed Oil | 8.7 | 12.4 | 15.0 | 62.5 | 1.4 |
15~22.5% seal oils | 28.6 | 45.0 | 1.4 | 22.5 | 2.5 |
30% seal oil | 17.0 | 30.0 | 16.5 | 32.0 | 4.5 |
55% seal oil | 15.0 | 25.0 | 55.0 | 5.0 | |
40% algal oil | 35.7 | 22.1 | 1.3 | 40.0 | |
60% algal oil | 27.0 | 12.2 | 60.8 |
Table 2, Chinese residents diet energy recommended intake (RNIs)
Age/year | Type | RNI/(MJ/d) | Age/year | Type | RNI/(MJ/d) | ||
The man | The woman | The man | The woman | ||||
0~ | 0.40MJ/(kg.d)① | 18~ | Light physical labor | 10.04 | 8.80 | ||
0.5~ | 0.40MJ/(kg.d)① | Middle physical exertion | 11.30 | 9.62 | |||
1~ | 4.60 | 4.40 | Ass work is moving | 13.38 | 11.30 | ||
2~ | 5.02 | 4.81 | Pregnant woman's (4~June) | +0.84 | |||
3~ | 5.64 | 5.43 | Pregnant woman's (7~September) | +0.84 | |||
4~ | 6.06 | 5.85 | Wet nurse | +2.09 | |||
5~ | 6.70 | 6.27 | 50~ | Light physical labor | 9.62 | 7.94 | |
6~ | 7.10 | 6.70 | Middle manual labor | 10.87 | 8.36 | ||
7~ | 7.53 | 7.10 | Heavy physical labour | 13.00 | 9.20 | ||
8~ | 7.94 | 7.53 | 60~ | Light physical labor | 7.94 | 7.53 | |
9~ | 8.36 | 7.94 | Middle manual labor | 9.20 | 8.36 | ||
10~ | 8.80 | 8.36 | 70~ | Light physical labor | 7.94 | 7.10 | |
11~ | 10.04 | 9.20 | Middle manual labor | 8.80 | 7.94 | ||
14~ | 12.12 | 10.04 | 80~ | 7.94 | 7.10 |
1. be AI, NBF should increase by 20% (DRIs, 2000)
Table 3, Chinese residents dietary fat recommended intake
Age/year | Type | Total fatty intake (g/d) | Age/year | Type | Total fatty intake (g/d) | ||
The man | The woman | The man | The woman | ||||
0~ | 3.27g/(kg.d)① | 18~ | Light physical labor | 82.04 | 71.93 | ||
0.5~ | 3.27g/(kg.d)① | Middle physical exertion | 92.37 | 78.64 | |||
1~ | 37.60 | 35.97 | Ass work is moving | 109.37 | 92.37 | ||
2~ | 41.04 | 39.32 | Pregnant woman's (4~June) | 99.23 | |||
3~ | 46.10 | 44.39 | Pregnant woman's (7~September) | 99.23 | |||
4~ | 49.54 | 47.82 | Wet nurse | 109.45 | |||
5~ | 54.77 | 51.25 | 50~ | Light physical labor | 78.64 | 64.90 | |
6~ | 58.04 | 54.77 | Middle manual labor | 88.85 | 68.34 | ||
7~ | 61.55 | 58.04 | Heavy physical labour | 106.26 | 75.20 | ||
8~ | 64.90 | 61.55 | 60~ | Light physical labor | 64.90 | 61.55 | |
9~ | 68.34 | 64.90 | Middle manual labor | 75.20 | 68.34 | ||
10~ | 71.93 | 68.34 | 70~ | Light physical labor | 64.90 | 58.04 | |
11~ | 82.07 | 75.20 | Middle manual labor | 71.93 | 64.90 | ||
14~ | 99.15 | 82.07 | 80~ | 64.90 | 58.04 |
1. be AI, NBF should increase by 20%, calculates according to " DRIs " (2000) that Chinese Soclety of Nutrition is recommended.
2. saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) ginseng recommended intake are 0.333 * total fatty intake (calculating by 1: 1: 1); ω-6 is that the aliphatic acid intake is 0.266 * total fatty intake~0.283g * total fatty intake in the polyunsaturated fatty acid (PUFA), and ω-3 is that the aliphatic acid intake is 0.067 * total fatty intake~0.048g * total fatty intake (calculating by 4~6: 1).
Table 4, sample DHA, EPA, DPA assay result (g/100g)
Sample | No. 1 | No. 2 | ||||||
EPA | DPA | DHA | Add up to | EPA | DPA | DHA | Add up to | |
A (not heating) | ||||||||
Content | 0.73 | 18.32 | 42.31 | 61.36 | 0.04 | 0.92 | 2.12 | 3.08 |
B (being heated to 200 ℃) | ||||||||
Content | 0.72 | 18.14 | 41.89 | 60.75 | --- | 0.91 | 2.10 | 3.01 |
Storage rate (%) | 98.6 | 99.0 | 99.0 | 99.0 | 98.9 | 99.1 | 97.7 | |
C (200 ℃~250 ℃ kept 2 minutes) | ||||||||
Content | 0.69 | 7.47 | 40.25 | 58.41 | --- | 0.87 | 2.05 | 2.92 |
Storage rate (%) | 94.5 | 95.4 | 95.1 | 95.2 | 94.6 | 96.7 | 94.8 | |
D (200 ℃~250 ℃ kept 4 minutes) | ||||||||
Content | 0.67 | 17.09 | 39.51 | 57.27 | --- | 0.83 | 1.98 | 2.81 |
Storage rate (%) | 91.8 | 93.3 | 93.4 | 93.3 | 90.2 | 93.4 | 91.2 | |
E (200 ℃~250 ℃ kept 6 minutes) | ||||||||
Content | 0.66 | 16.79 | 38.62 | 56.07 | --- | 0.82 | 1.96 | 2.78 |
Storage rate (%) | 90.4 | 91.6 | 91.3 | 91.4 | 89.1 | 93.3 | 90.3 |
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)
Embodiment | The prescription grease | |||||||||||||
Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
1 | 31.5 | 10 | 18 | 5 | 6 | 23 | 4 | 0.02 | ||||||
2 | 31.4 | 10 | 18 | 5 | 6 | 23 | 4 | 0.01 | 0.02 | |||||
3 | 31.5 | 10 | 18 | 5 | 6 | 23 | 4 | 0.03 | ||||||
4 | 29 | 10 | 18 | 5 | 6 | 23 | 4 | 0.01 | ||||||
5 | 39.5 | 10 | 20 | 4 | 6 | 18 | 0.01 | |||||||
6 | 32.4 | 10 | 20 | 4 | 6 | 18 | 0.008 | 0.02 | ||||||
7 | 38.7 | 10 | 20 | 4 | 6 | 18 | 0.01 | 0.02 | ||||||
8 | 43.5 | 10 | 20 | 6 | 10 | 8 | 0.008 | 0.02 | ||||||
9 | 43.5 | 10 | 20 | 6 | 10 | 8 | 0.01 | |||||||
10 | 42.7 | 10 | 20 | 6 | 10 | 8 | 0.01 | |||||||
11 | 43.8 | 10 | 20 | 10 | 8 | 0.008 | 0.01 | |||||||
12 | 21.5 | 15 | 3 | 28 | 6 | 24 | 0.01 | |||||||
13 | 21.5 | 15 | 3 | 28 | 6 | 24 | 0.008 | 0.02 | ||||||
14 | 20.7 | 15 | 3 | 28 | 6 | 24 | 0.008 | 0.02 | ||||||
15 | 21.5 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
16 | 21.5 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
17 | 20.7 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
18 | 25.5 | 15 | 5 | 7 | 17 | 23 | 5 | 0.01 | ||||||
19 | 25.5 | 15 | 5 | 7 | 17 | 23 | 5 | 0.01 | ||||||
20 | 24 | 15 | 5 | 10.8 | 17 | 23 | 5 | 0.008 | 0.02 |
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)-continuous 1
Embodiment | The prescription grease | |||||||||||||
Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
21 | 26.5 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
22 | 27.4 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.08 | |||||
23 | 26.5 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
24 | 24 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.08 | |||||
25 | 26.5 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
26 | 26.5 | 15 | 5 | 15 | 8 | 5 | 23 | 0.2 | ||||||
27 | 24 | 15 | 5 | 15 | 8 | 5 | 23 | 0.12 | ||||||
28 | 25.7 | 15 | 5 | 15 | 8 | 5 | 23 | 0.12 | ||||||
29 | 31.5 | 15 | 5 | 7 | 14 | 5 | 20 | 0.002 | 0.06 | |||||
30 | 32.4 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
31 | 31.5 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
32 | 30.7 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
33 | 31.5 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
34 | 32.4 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
35 | 31.5 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
36 | 30.7 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
37 | 39.5 | 32 | 6 | 20 | 0.002 | 0.08 | ||||||||
38 | 39.5 | 32 | 6 | 20 | 0.003 | 0.05 | ||||||||
39 | 38.7 | 32 | 6 | 20 | 0.003 | 0.05 | ||||||||
40 | 36.5 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 |
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)-continuous 2
Embodiment | The prescription grease | |||||||||||||
Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
41 | 34 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 | ||||||
42 | 36.5 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 | ||||||
43 | 26.5 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
44 | 27.4 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
45 | 26.5 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
46 | 25.7 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
47 | 30.5 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
48 | 31.4 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
49 | 30.5 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
50 | 29.7 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
51 | 22.5 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
52 | 23.4 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
53 | 22.5 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
54 | 21.5 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
55 | 21.5 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
56 | 20.7 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
57 | 21.5 | 36 | 35 | 5 | 0.005 | 0.02 | ||||||||
58 | 22.4 | 36 | 35 | 5 | 0.008 | |||||||||
59 | 21.5 | 36 | 35 | 5 | 0.008 | |||||||||
60 | 20.7 | 36 | 35 | 5 | 0.005 | 0.01 |
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)-continuous 3
Embodiment | The prescription grease | |||||||||||||
Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
61 | 21.5 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
62 | 21.5 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
63 | 20.7 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
64 | 26.5 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
65 | 27.4 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
66 | 25.7 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
67 | 26.5 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
68 | 26.5 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 | ||||||
69 | 26.5 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 | ||||||
70 | 25.7 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 |
Table 6, embodiment admix oily algal oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)
Embodiment | Algal oil | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
Addition | ω-3 long-chain polyunsaturated fatty acid accounts for the percentage composition of algal oil | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||||
Percent of total | DHA percentage | DPA percentage | EPA percentage | Total content | DHA/ (DPA+EPA) | DHA/EPA | ||||||
1 | 2.5 | 40 | 16 | 15 | 9 | 15.4 | 42.6 | 35.9 | 6.0 | 1.0 | 0.67∶1 | 1.78∶1 |
2 | 1.35 | 60 | 24 | 22 | 14.8 | 15.1 | 42.3 | 36.2 | 6.0 | 1.0 | 0.65∶1 | 1.62∶1 |
3 | 2.5 | 60 | 24 | 22 | 14.8 | 15.2 | 42.3 | 36.5 | 6.4 | 1.5 | 0.65∶1 | 1.62∶1 |
4 | 5.0 | 40 | 16 | 15 | 9 | 15.8 | 42.1 | 35.6 | 7.0 | 2.0 | 0.67∶1 | 1.78∶1 |
5 | 2.5 | 40 | 16 | 15 | 9 | 16.2 | 41.6 | 35.9 | 6.2 | 1.0 | 0.67∶1 | 1.78∶1 |
6 | 1.65 | 60 | 12.2 | 28 | 20.6 | 16.0 | 41.7 | 36.2 | 6.2 | 1.0 | 0.25∶1 | 0.59∶1 |
7 | 3.3 | 60 | 24 | 22 | 14.8 | 16.1 | 41.2 | 35.6 | 7.2 | 2.0 | 0.65∶1 | 1.62∶1 |
8 | 2.5 | 40 | 16 | 15 | 9 | 16.4 | 42.2 | 35.4 | 6.2 | 1.0 | 0.67∶1 | 1.78∶1 |
9 | 2.5 | 60 | 24 | 22 | 14.8 | 16.2 | 41.9 | 35.3 | 6.7 | 1.5 | 0.65∶1 | 1.62∶1 |
10 | 3.3 | 60 | 25 | 21 | 14.8 | 16.2 | 41.7 | 35.0 | 7.2 | 2.0 | 0.70∶1 | 1.69∶1 |
11 | 8.25 | 60 | 24 | 22 | 14.8 | 17.0 | 41.5 | 34.1 | 7.2 | 5.0 | 0.65∶1 | 1.62∶1 |
12 | 2.5 | 40 | 16 | 15 | 9 | 15.0 | 42.1 | 36.2 | 6.6 | 1.0 | 0.67∶1 | 1.78∶1 |
13 | 2.5 | 60 | 24 | 22 | 14.8 | 14.8 | 41.9 | 36.1 | 7.1 | 1.5 | 0.65∶1 | 1.62∶1 |
14 | 3.3 | 60 | 24 | 22 | 14.8 | 14.8 | 41.6 | 35.8 | 7.6 | 2.0 | 0.65∶1 | 1.62∶1 |
15 | 2.5 | 40 | 16 | 15 | 9 | 15.0 | 42.2 | 35.1 | 6.6 | 1.0 | 0.67∶1 | 1.78∶1 |
16 | 2.5 | 60 | 24 | 22 | 14.8 | 14.6 | 42.0 | 35.8 | 7.1 | 1.5 | 0.65∶1 | 1.62∶1 |
17 | 3.3 | 60 | 24 | 22 | 14.8 | 14.8 | 41.7 | 35.8 | 7.6 | 2.0 | 0.65∶1 | 1.62∶1 |
18 | 2.5 | 40 | 16 | 15 | 9 | 15.2 | 42.1 | 36.2 | 6.4 | 1.0 | 0.67∶1 | 1.78∶1 |
19 | 2.5 | 60 | 24 | 22 | 14.8 | 14.9 | 43.0 | 36.8 | 6.8 | 1.5 | 0.65∶1 | 1.62∶1 |
20 | 0.25 | 40 | 16 | 15 | 9 | 14.5 | 41.7 | 36.2 | 7.3 | 0.1 | 0.67∶1 | 1.78∶1 |
Table 6, embodiment admix oily algal oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 1
Embodiment | Algal oil | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
Addition | ω-3 long-chain polyunsaturated fatty acid accounts for the percentage composition of algal oil | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||||
Percent of total | DHA percentage | DPA percentage | EPA percentage | Total content | DHA/ (DPA+EPA) | DHA/EPA | ||||||
21 | 2.5 | 40 | 28 | 11.4 | 0.6 | 14.7 | 42.3 | 36.0 | 6.9 | 1.0 | 2.3∶1 | 46.7∶1 |
22 | 1.65 | 60 | 42 | 18 | 0.8 | 14.5 | 42.3 | 36.3 | 6.9 | 1.0 | 2.2∶1 | 52.5∶1 |
23 | 2.5 | 60 | 42 | 18 | 0.8 | 14.5 | 42.1 | 36.0 | 7.4 | 1.5 | 2.2∶1 | 52.5∶1 |
24 | 5.0 | 40 | 26.67 | 10.63 | 2.67 | 15.2 | 41.8 | 35.1 | 7.8 | 2.0 | 2.0∶1 | 10∶1 |
25 | 2.5 | 40 | 28 | 11.4 | 0.6 | 14.5 | 41.8 | 36.0 | 6.7 | 1.0 | 2.3∶1 | 46.7∶1 |
26 | 2.5 | 60 | 42 | 18 | 0.8 | 14.3 | 41.6 | 36.3 | 6.9 | 1.0 | 2.2∶1 | 52.5∶1 |
27 | 5.0 | 40 | 36.90 | 3.08 | 0.615 | 14.9 | 41.3 | 36.0 | 7.4 | 1.5 | 10.0∶1 | 60.0∶1 |
28 | 3.3 | 60 | 42 | 18 | 0.8 | 14.3 | 41.3 | 35.1 | 7.8 | 2.0 | 2.2∶1 | 52.5∶1 |
29 | 2.5 | 40 | 28 | 11.4 | 0.6 | 15.6 | 41.9 | 36.2 | 7.3 | 1.0 | 2.3∶1 | 46.7∶1 |
30 | 1.65 | 60 | 40 | 20 | --- | 15.3 | 41.9 | 36.2 | 7.9 | 1.0 | 2.0∶1 | --- |
31 | 2.5 | 60 | 42 | 18 | 0.8 | 15.4 | 41.7 | 35.3 | 8.3 | 1.5 | 2.2∶1 | 52.5∶1 |
32 | 3.3 | 60 | 42 | 18 | 0.8 | 15.4 | 41.4 | 35.9 | 8.3 | 2.0 | 2.2∶1 | 52.5∶1 |
33 | 2.5 | 40 | 28 | 11.4 | 0.6 | 15.4 | 41.5 | 35.7 | 6.6 | 1.0 | 2.3∶1 | 46.7∶1 |
34 | 1.65 | 60 | 42 | 18 | 0.8 | 15.1 | 41.5 | 36.0 | 6.6 | 1.0 | 2.2∶1 | 52.5∶1 |
35 | 2.5 | 60 | 42 | 18 | 0.8 | 15.2 | 41.2 | 35.7 | 7.1 | 1.5 | 2.2∶1 | 52.5∶1 |
36 | 3.3 | 60 | 54.55 | 5.45 | --- | 15.2 | 41.0 | 35.7 | 7.8 | 2.0 | 10.0∶1 | --- |
37 | 2.5 | 40 | 28 | 11.4 | 0.6 | 16.5 | 42.2 | 34.1 | 6.9 | 1.0 | 2.3∶1 | 46.7∶1 |
38 | 2.5 | 60 | 42 | 18 | 0.8 | 16.2 | 42.0 | 34.0 | 7.4 | 1.5 | 2.2∶1 | 52.5∶1 |
39 | 3.3 | 60 | 42 | 18 | 0.8 | 16.3 | 42.7 | 33.7 | 7.9 | 2.0 | 2.2∶1 | 52.5∶1 |
40 | 2.5 | 40 | 28 | 12 | 0.6 | 15.8 | 41.8 | 35.2 | 7.1 | 1.0 | 2.2∶1 | 46.7∶1 |
Table 6, embodiment admix oily algal oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 2
Embodiment | Algal oil | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
Addition | ω-3 long-chain polyunsaturated fatty acid accounts for the percentage composition of algal oil | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||||
Percent of total | DHA percentage | DPA percentage | EPA percentage | Total content | DHA/ (DPA+EPA) | DHA/EPA | ||||||
41 | 5.0 | 40 | 40 | --- | --- | 16.3 | 41.3 | 34.3 | 8.0 | 2.0 | --- | --- |
42 | 2.5 | 60 | 42 | 18 | 0.8 | 15.6 | 41.2 | 35.1 | 7.6 | 1.5 | 2.2∶1 | 52.5∶1 |
43 | 2.5 | 40 | 30 | 6 | 4 | 13.8 | 43.1 | 35.6 | 7.4 | 1.0 | 3.0∶1 | 7.5∶1 |
44 | 1.65 | 60 | 55.27 | --- | 5.53 | 13.5 | 42.1 | 35.9 | 7.4 | 1.0 | 10.0∶1 | 10.0∶1 |
45 | 2.5 | 60 | 42 | 12.8 | 6 | 13.6 | 42.8 | 35.6 | 7.9 | 1.5 | 2.2∶1 | 7.0∶1 |
46 | 3.3 | 60 | 42 | 12.8 | 6 | 13.6 | 42.6 | 35.3 | 8.4 | 2.0 | 2.2∶1 | 7.0∶1 |
47 | 2.5 | 40 | 26.67 | 6.66 | 6.66 | 14.2 | 43.2 | 35.3 | 7.2 | 1.0 | 2.0∶1 | 4.0∶1 |
48 | 1.65 | 60 | 42 | 12.8 | 6 | 14.0 | 43.2 | 35.6 | 7.3 | 1.0 | 2.2∶1 | 7.0∶1 |
49 | 2.5 | 60 | 42 | 12.8 | 6 | 14.0 | 43.0 | 35.3 | 7.8 | 1.5 | 2.2∶1 | 7.0∶1 |
50 | 3.3 | 60 | 42 | 12.8 | 6 | 14.1 | 42.7 | 35.0 | 8.2 | 2.0 | 2.2∶1 | 7.0∶1 |
51 | 2.5 | 40 | 30 | 6 | 4 | 13.5 | 43.8 | 35.1 | 6.6 | 1.0 | 3.0∶1 | 7.5∶1 |
52 | 1.65 | 60 | 42 | 12.8 | 6 | 13.2 | 43.8 | 35.4 | 6.6 | 1.0 | 2.2∶1 | 7.0∶1 |
53 | 2.5 | 60 | 42 | 12.8 | 6 | 13.3 | 43.5 | 35.0 | 7.1 | 1.5 | 2.2∶1 | 7.0∶1 |
54 | 2.5 | 40 | 30 | 6 | 4 | 13.5 | 43.5 | 35.7 | 6.4 | 1.0 | 3.0∶1 | 7.5∶1 |
55 | 2.5 | 60 | 42 | 12.8 | 6 | 13.3 | 43.3 | 35.6 | 6.9 | 1.5 | 2.2∶1 | 7.0∶1 |
56 | 3.3 | 60 | 42 | 12.8 | 6 | 13.4 | 43.4 | 36.1 | 7.4 | 2.0 | 2.2∶1 | 7.0∶1 |
57 | 2.5 | 40 | 20 | 16 | 4 | 14.1 | 42.9 | 35.6 | 7.3 | 1.0 | 1.0∶1 | 5.0∶1 |
58 | 1.65 | 60 | 30 | 24 | 6.8 | 13.8 | 42.8 | 35.9 | 7.3 | 1.0 | 0.97∶1 | 4.4∶1 |
59 | 2.5 | 60 | 30 | 24 | 6.8 | 13.9 | 42.7 | 35.6 | 7.8 | 1.5 | 0.97∶1 | 4.4∶1 |
60 | 3.3 | 60 | 25 | 29 | 6.8 | 14.0 | 42.4 | 35.3 | 8.3 | 2.0 | 0.70∶1 | 3.7∶1 |
Table 6, embodiment admix oily seal oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 3
Embodiment | Algal oil | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
Addition | ω-3 long-chain polyunsaturated fatty acid accounts for the percentage composition of algal oil | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||||
Percent of total | DHA percentage | DPA percentage | EPA percentage | Total content | DHA/ (DPA+EPA) | DHA/EPA | ||||||
61 | 2.5 | 40 | 20 | 16 | 4 | 13.0 | 44.2 | 37.2 | 7.2 | 1.0 | 1.0∶1 | 5.0∶1 |
62 | 2.5 | 60 | 30 | 24 | 6.8 | 12.8 | 43.9 | 37.1 | 7.7 | 1.5 | 0.97∶1 | 4.4∶1 |
63 | 3.3 | 60 | 30 | 24 | 6.8 | 12.9 | 43.7 | 36.8 | 8.2 | 2.0 | 0.97∶1 | 4.4∶1 |
64 | 2.5 | 40 | 20 | 16 | 4 | 13.4 | 44.6 | 34.6 | 7.4 | 1.0 | 1.0∶1 | 5.0∶1 |
65 | 1.65 | 60 | 40.5 | 15 | 5.3 | 13.2 | 44.6 | 34.9 | 7.4 | 1.0 | 2.0∶1 | 7.6∶1 |
66 | 3.3 | 60 | 30 | 24 | 6.8 | 13.3 | 44.1 | 34.3 | 8.4 | 2.0 | 0.97∶1 | 4.4∶1 |
67 | 2.5 | 60 | 30 | 24 | 6.8 | 13.2 | 44.3 | 34.6 | 7.9 | 1.5 | 0.97∶1 | 4.4∶1 |
68 | 2.5 | 40 | 20 | 16 | 4 | 13.8 | 44.2 | 34.8 | 7.0 | 1.0 | 1.0∶1 | 5.0∶1 |
69 | 2.5 | 60 | 30 | 24 | 6.8 | 13.6 | 43.9 | 34.7 | 7.5 | 1.5 | 0.97∶1 | 4.4∶1 |
70 | 3.3 | 60 | 30 | 24 | 6.8 | 13.7 | 43.7 | 34.4 | 8.0 | 2.0 | 0.97∶1 | 4.4∶1 |
Claims (10)
1. nutrient blend oil is characterized in that: it is to add algal oil and make in edible oil.
2. nutrient blend oil according to claim 1, it is characterized in that: the addition of described algal oil is to decide according to the total content of contained ω-3 long-chain polyunsaturated fatty acid in the algal oil (ω-3 LCPUFA), promptly (ω-3LCPUFA) total amount is 0.1~5.0g modulation by containing ω-3 long-chain polyunsaturated fatty acid in every 100g finished product ready-mixed oil behind the interpolation algal oil, described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA), the combination of one or two or more kinds in eicosapentaenoic acid (EPA) or the clupanodonic acid (DPA), described vegetable fat consists of refine peanut oil, the refining sunflower oil, the two low rapeseed oils of refining, purified soyabean oil, refined sesame oil, the refining linseed oil, refined maize's oil, the refining Purple Perilla Seed Oil, the refining walnut oil, the refining tea-seed oil, the refining safflower seed oil, four or more combination in the refined olive oil, its weight ratio is:
Refine peanut oil 20.7~43.8g refining sunflower oil 0~27g
The two low rapeseed oil 0~40g purified soyabean oil 0~35g of refining
Refined sesame oil 0~5g refining linseed oil 0~10.8g
Oil 0~the 28g of refined maize refining Purple Perilla Seed Oil 0~8g
Refining walnut oil 0~5g refining tea-seed oil 0~24g
Refining safflower seed oil 0~5g refined olive oil 0~8g.
3. nutrient blend oil according to claim 2, it is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA), eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA), described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=2: 1~10: 1, DHA (DHA) is DHA: EPA=4 with eicosapentaenoic acid (EPA) weight ratio R: 1~10: 1.
4. nutrient blend oil according to claim 2, it is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA), eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA), described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=2: 1~10: 1, DHA (DHA) is DHA: EPA=10 with the weight ratio R of eicosapentaenoic acid (EPA): 1~60: 1.
5. nutrient blend oil according to claim 2, it is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA) and two kinds of combinations of clupanodonic acid (DPA), described DHA (DHA) and clupanodonic acid (DPA) weight ratio S
Be DHA: DPA=2: 1~10: 1.
6. nutrient blend oil according to claim 2 is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is a DHA (DHA).
7. nutrient blend oil according to claim 2, it is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA) and eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA), and described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=0.7: 1~2: 1.
8. nutrient blend oil according to claim 2, it is characterized in that: described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is DHA (DHA) and eicosapentaenoic acid (EPA) or three kinds of combinations of clupanodonic acid (DPA), described DHA (DHA) is DHA with the weight ratio Q that clupanodonic acid (DPA) adds eicosapentaenoic acid (EPA): (EPA+DPA)=0.25: 1~0.7: 1, described vegetable fat consists of refine peanut oil, the refining sunflower oil, purified soyabean oil, refined sesame oil, the refining linseed oil, refined maize's oil, the refining Purple Perilla Seed Oil, the refining walnut oil, the refining tea-seed oil, the refining safflower seed oil, four or more above combination in the refined olive oil.
9. according to each described nutrient blend oil of claim 3~8, it is characterized in that: added antioxidant in the described vegetable fat, described antioxidant is one or both the combination in fat-soluble tea polyphenol and the vitamin E, described fat-soluble tea polyphenol addition is to contain 0.002~0.03g in every 100g finished product ready-mixed oil, and described vitamin E addition is to contain 0.01~0.2g in every 100g finished product ready-mixed oil.
10. the production method of a nutrient blend oil is characterized in that comprising the steps:
(1) selected needed raw material edible oil;
(2) require the algal oil of selected required interpolation according to the weight ratio between the total amount of finished product ready-mixed oil required ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) and DHA, DPA, the EPA;
(3) weight ratio between the addition of the following relational expression calculating of foundation algal oil and DHA, DPA, the EPA:
ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) weight (W) with the relational expression of algal oil addition is in per 100 gram finished product ready-mixed oils
W=Wb×Xb
DHA and EPA weight ratio relational expression are in ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA and EPA weight ratio (R) and the algal oil
R=X
DHA/X
EPA=X
DHAb/X
EPAb
DHA with (DPA+EPA) weight ratio relational expression is in ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA and (DPA+EPA) weight ratio (Q) and the algal oil
Q=X
DHA/(X
DPA+X
EPA)=X
DHAb/(X
DPAb+X
EPAb)
DHA and DPA weight ratio relational expression are in ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA and DPA weight ratio (S) and the algal oil
S=X
DHA/X
DPA=X
DHAb/X
DPAb
The relational expression that ω in the algal oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount, DHA, DPA, EPA weight account for its percentage by weight is:
Xb=X
DHAb+X
DPAb+X
EPAb
In the above-mentioned relation formula:
W is ω-3 long-chain polyunsaturated fatty acid (ω-3 a LCPUFA) weight in per 100 gram finished product ready-mixed oils, and its weight range is 0.1~5.0g;
Wb is the weight of the algal oil that adds in per 100 gram finished product ready-mixed oils; Xb accounts for the percentage of its gross weight for ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) weight (DHA+EPA+DPA) in the algal oil that adds;
X
DHAN, X
EPA, X
DPABe respectively DHA, EPA in the finished product ready-mixed oil, DPA weight accounts for its percentage by weight; X
DHAb, X
EPAb, X
DPAbBe respectively DHA in the algal oil, EPA, DPA weight accounts for its percentage by weight.
(4) according to containing saturated fatty acid (SFA) 12~18g in the 100 gram finished product ready-mixed oils, monounsaturated fatty acids (MUFA) 39~46g, omega 6 polyunsaturated fatty acid (ω-6 PUFA) 31~38g, the requirement of omega-3 polyunsaturated fatty acids (ω-3 PUFA) 5~9g, according to saturated aliphatic acid (SFA), monounsaturated fatty acids (MUFA), omega 6 polyunsaturated fatty acid (ω-6 PUFA), omega-3 polyunsaturated fatty acids (ω-3 PUFA) percentage composition in the algal oil of required interpolation, the various raw material edible oil, calculate the portion that all kinds of raw material edible oils should add.
(5) get the algal oil of calculating portion and the antioxidant of raw material edible oil and ormal weight, add in the material-compound tank, holding temperature is stirred at a slow speed and mixes (general 20~30 minutes) at 20~40 ℃, filters, and promptly gets the ready-mixed oil finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100358007A CN100521953C (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing algal oil and producing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100358007A CN100521953C (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing algal oil and producing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101124929A true CN101124929A (en) | 2008-02-20 |
CN100521953C CN100521953C (en) | 2009-08-05 |
Family
ID=39093133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100358007A Expired - Fee Related CN100521953C (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing algal oil and producing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100521953C (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102204594A (en) * | 2011-04-11 | 2011-10-05 | 山东三星玉米产业科技有限公司 | DHA (docosahexaenoic acid)-containing grain blend oil and preparation method thereof |
CN102578306A (en) * | 2012-03-09 | 2012-07-18 | 山东渤海实业股份有限公司 | Docosahexaenoic acid (DHA)-containing compound soybean oil |
CN102599264A (en) * | 2012-03-09 | 2012-07-25 | 山东渤海实业股份有限公司 | Preparation method for DHA (Docosahexenoic Acid)-fortified soybean oil |
CN102742669A (en) * | 2012-07-02 | 2012-10-24 | 湖南金点油脂有限公司 | Edible blend oil for promoting development of infant brain and nerve cell |
CN103156003A (en) * | 2011-12-16 | 2013-06-19 | 丰益(上海)生物技术研发中心有限公司 | Blend oil and preparation method thereof |
CN101926394B (en) * | 2009-06-25 | 2013-09-04 | 上海良友(集团)有限公司 | Edible blended oil with high stability |
CN104255950A (en) * | 2014-09-19 | 2015-01-07 | 广东润科生物工程有限公司 | Rapeseed blend oil containing docosahexaenoic acid (DHA), and preparation method thereof |
CN104255944A (en) * | 2014-09-19 | 2015-01-07 | 广东润科生物工程有限公司 | DHA-containing olive blending oil and preparation method thereof |
CN104642567A (en) * | 2014-12-18 | 2015-05-27 | 青岛博之源生物技术有限公司 | Nutritional blend oil added with seal oil |
CN106509158A (en) * | 2016-10-11 | 2017-03-22 | 洪细东 | Healthy blend oil |
CN107183219A (en) * | 2017-06-30 | 2017-09-22 | 天津市中英保健食品有限公司 | A kind of low temperature nutrient blend oil and preparation method thereof |
CN107822143A (en) * | 2017-11-27 | 2018-03-23 | 北京市营养源研究所 | Compound grease microcapsule that a kind of Fatty acids composition is reasonable, stability is high and preparation method thereof |
CN108402188A (en) * | 2018-01-30 | 2018-08-17 | 湖南嘉耘油脂有限公司 | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid |
CN111743013A (en) * | 2020-07-31 | 2020-10-09 | 中粮工科(西安)国际工程有限公司 | EPA nutrient-enriched blend oil suitable for middle-aged and elderly people and preparation method thereof |
TWI765535B (en) * | 2021-01-18 | 2022-05-21 | 健茂生物科技股份有限公司 | Health product composition containing plant-based oils |
-
2007
- 2007-09-24 CN CNB2007100358007A patent/CN100521953C/en not_active Expired - Fee Related
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101926394B (en) * | 2009-06-25 | 2013-09-04 | 上海良友(集团)有限公司 | Edible blended oil with high stability |
CN102204594A (en) * | 2011-04-11 | 2011-10-05 | 山东三星玉米产业科技有限公司 | DHA (docosahexaenoic acid)-containing grain blend oil and preparation method thereof |
CN103156003A (en) * | 2011-12-16 | 2013-06-19 | 丰益(上海)生物技术研发中心有限公司 | Blend oil and preparation method thereof |
CN103156003B (en) * | 2011-12-16 | 2015-04-29 | 丰益(上海)生物技术研发中心有限公司 | Blend oil and preparation method thereof |
CN102578306A (en) * | 2012-03-09 | 2012-07-18 | 山东渤海实业股份有限公司 | Docosahexaenoic acid (DHA)-containing compound soybean oil |
CN102599264A (en) * | 2012-03-09 | 2012-07-25 | 山东渤海实业股份有限公司 | Preparation method for DHA (Docosahexenoic Acid)-fortified soybean oil |
CN102742669A (en) * | 2012-07-02 | 2012-10-24 | 湖南金点油脂有限公司 | Edible blend oil for promoting development of infant brain and nerve cell |
CN102742669B (en) * | 2012-07-02 | 2013-07-17 | 湖南金点油脂有限公司 | Edible blend oil for promoting development of infant brain and nerve cell |
CN104255944A (en) * | 2014-09-19 | 2015-01-07 | 广东润科生物工程有限公司 | DHA-containing olive blending oil and preparation method thereof |
CN104255950A (en) * | 2014-09-19 | 2015-01-07 | 广东润科生物工程有限公司 | Rapeseed blend oil containing docosahexaenoic acid (DHA), and preparation method thereof |
CN104642567A (en) * | 2014-12-18 | 2015-05-27 | 青岛博之源生物技术有限公司 | Nutritional blend oil added with seal oil |
CN106509158A (en) * | 2016-10-11 | 2017-03-22 | 洪细东 | Healthy blend oil |
CN107183219A (en) * | 2017-06-30 | 2017-09-22 | 天津市中英保健食品有限公司 | A kind of low temperature nutrient blend oil and preparation method thereof |
CN107822143A (en) * | 2017-11-27 | 2018-03-23 | 北京市营养源研究所 | Compound grease microcapsule that a kind of Fatty acids composition is reasonable, stability is high and preparation method thereof |
CN108402188A (en) * | 2018-01-30 | 2018-08-17 | 湖南嘉耘油脂有限公司 | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid |
CN111743013A (en) * | 2020-07-31 | 2020-10-09 | 中粮工科(西安)国际工程有限公司 | EPA nutrient-enriched blend oil suitable for middle-aged and elderly people and preparation method thereof |
TWI765535B (en) * | 2021-01-18 | 2022-05-21 | 健茂生物科技股份有限公司 | Health product composition containing plant-based oils |
Also Published As
Publication number | Publication date |
---|---|
CN100521953C (en) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100542411C (en) | A kind of nutrition balanced mixed oil and production method thereof that contains omega-3 polyunsaturated fatty acids | |
CN100521953C (en) | Nutrition balanced mixed oil containing algal oil and producing method thereof | |
CN101142947A (en) | Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method | |
CN103493908B (en) | Nut blend oil with lipid lowering and blood glucose reducing effects and preparation method thereof | |
CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
CN108402188A (en) | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid | |
CN104719510A (en) | Pregnant woman and infant nutritional tea oil containing DHA and AA | |
CN102422905B (en) | Siritch-flavored seasoning oil | |
CN101088349B (en) | Edible blend oil containing docosahexenoic acid | |
CN101617721A (en) | Balanced-nutrition healthy edible blend oil with brain tonic efficacy | |
CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
CN102894107A (en) | Nutritional walnut oil and production process thereof | |
CN108703375A (en) | Weight losing function food containing conjugated linoleic acid | |
CN106615178A (en) | Solid DHA (docosahexaenoic acid) algae oil beverage | |
CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
CN100508769C (en) | Nutrition balanced mixed oil containing seal oil and production method thereof | |
CN105707292A (en) | Camellia blend oil suitable for infants | |
CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
CN103518867A (en) | Natural cereal blend oil | |
CN102106410A (en) | Camellia seed nutritional oil for pregnant women | |
CN110353056A (en) | A kind of edible vegetable blend oil | |
CN101700080A (en) | Edible oil for specially supplementing alpha-linolenic acid nutrient | |
CN103416729A (en) | Mayonnaise rich in alpha-linolenic acid | |
CN109938152A (en) | A kind of sandwich soft sweets of tea-seed oil of nutrition brain tonic and preparation method thereof | |
CN106343045A (en) | Nutrient enrichment functional low-temperature edible blend grease containing enriched in long carbon chain polyunsaturated fatty acid lipoids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090805 Termination date: 20160924 |